ABSTRACT
BACKGROUND: Mycobacterial infections are important and potentially life-threatening complications after organ transplantations. Notably, for the recipients of allogeneic hematopoietic stem cell transplantation (HSCT), there are a few supporting results to explore post-transplant mycobacterial infections. Taiwan is a high endemic area of the infection. We aim to investigate the incidence, risk factors, and survival of post-transplant mycobacterial infections, including mycobacterium tuberculosis (MTB) and non-tuberculous mycobacterium (NTM). METHODS: We included 422 adult patients undergoing allogeneic HSCT at an Asian tertiary medical center between January 2003 and December 2014. A total 26 subjects developed post-transplant mycobacterial infections. Risk factors, clinical features, and survival for post-transplant mycobacterial infections were collected and analyzed. RESULTS: Post-transplant mycobacterial infections occurred in 26 (6.2%) of 422 HSCT patients. Two-year cumulative incidences in MTB and NTM were 1.4% and 5.4%. In the multivariate analysis, being age >45 years (adjusted HR 2.21, 95% CI 1.01-4.83) and extensive chronic graft-versus-host disease (cGVHD) (adjusted HR 4.95, 95% CI 2.14-11.46) were identified as independent risk factors of infections. There was a trend as a risk factors in relapsed patients (P = 0.088). For patients with cGVHD, there was a significant difference of post-transplant survival between mycobacterial infections and none (P = 0.036). Pneumonia contributed most to mortality (n = 11, 42.3%). CONCLUSION: Mycobacterial infections are worth to note in a high endemic area. Once a high-risk group is identified, much effort is required to target new approaches for prevention, early detection and treatment of infections.
Subject(s)
Hematopoietic Stem Cell Transplantation/adverse effects , Mycobacterium Infections/complications , Mycobacterium Infections/epidemiology , Adult , Cohort Studies , Female , Graft vs Host Disease , Humans , Incidence , Male , Middle Aged , Mycobacterium , Mycobacterium Infections/diagnosis , Mycobacterium Infections/physiopathology , Retrospective Studies , Risk Factors , Taiwan/epidemiologyABSTRACT
Cardiovascular disease (CVD) is the leading cause of death in industrialized nations and an emerging health problem in the developing world. Systemic inflammatory processes associated with alterations in lipid metabolism are a major contributing factor that mediates the development of CVDs, especially atherosclerosis. Therefore, the pathways promoting alterations in lipid metabolism and the interplay between varying cellular types, signaling agents, and effector molecules have been well-studied. Mycobacterial species are the causative agents of various infectious diseases in both humans and animals. Modulation of host lipid metabolism by mycobacteria plays a prominent role in its survival strategy within the host as well as in disease pathogenesis. However, there are still several knowledge gaps in the mechanistic understanding of how mycobacteria can alter host lipid metabolism. Considering the in-depth research available in the area of cardiovascular research, this review presents an overview of the parallel areas of research in host lipid-mediated immunological changes that might be extrapolated and explored to understand the underlying basis of mycobacterial pathogenesis.
Subject(s)
Cardiovascular Diseases/pathology , Cardiovascular Diseases/physiopathology , Inflammation/pathology , Inflammation/physiopathology , Lipid Metabolism , Mycobacterium Infections/pathology , Mycobacterium Infections/physiopathology , Animals , Biomedical Research/trends , HumansABSTRACT
Murine leprosy, caused by Mycobacterium lepraemurium (MLM), is a chronic disease that closely resembles human leprosy. Even though this disease does not directly involve the nervous system, we investigated a possible effect on working memory during this chronic infection in Balb/c mice. We evaluated alterations in the dorsal region of the hippocampus and measured peripheral levels of cytokines at 40, 80, and 120 days post-infection. To evaluate working memory, we used the T-maze while a morphometric analysis was conducted in the hippocampus regions CA1, CA2, CA3, and dentate gyrus (DG) to measure morphological changes. In addition, a neurochemical analysis was performed by HPLC. Our results show that, at 40 days post-infection, there was an increase in the bacillary load in the liver and spleen associated to increased levels of IL-4, working memory deterioration, and changes in hippocampal morphology, including degeneration in the four subregions analyzed. Also, we found a decrease in neurotransmitter levels at the same time of infection. Although MLM does not directly infect the nervous system, these findings suggest a possible functional link between the immune system and the central nervous system.
Subject(s)
Hippocampus/physiopathology , Memory Disorders/physiopathology , Mycobacterium Infections/physiopathology , Animals , Chronic Disease , Dentate Gyrus/microbiology , Dentate Gyrus/pathology , Dentate Gyrus/physiopathology , Hippocampus/microbiology , Hippocampus/pathology , Host-Pathogen Interactions , Interleukin-4/metabolism , Male , Maze Learning , Memory Disorders/metabolism , Memory Disorders/microbiology , Memory, Short-Term , Mice, Inbred BALB C , Mycobacterium Infections/metabolism , Mycobacterium Infections/microbiology , Mycobacterium lepraemurium/physiology , Neurotransmitter Agents/metabolism , Time FactorsABSTRACT
OBJECTIVE: This study investigated an outbreak of Bartonellosis in a coastal region in Peru. RESULTS: A total of 70 (n = 70) samples with clinical criteria for the acute phase of Bartonellosis and a positive peripheral blood smear were included. 22.85% (n = 16) cases of the samples were positive for Bartonella bacilliformis by PCR and automatic sequencing. Of those positive samples, 62.5% (n = 10) cases were positive only for B. bacilliformis and 37.5% (n = 6) cases were positive to both Mycobacterium spp. and B. bacilliformis. The symptom frequencies were similar in patients diagnosed with Carrion's disease and those co-infected with Mycobacterium spp. The most common symptoms were headaches, followed by malaise and arthralgia.
Subject(s)
Bartonella Infections/epidemiology , Bartonella Infections/physiopathology , Bartonella bacilliformis/isolation & purification , Disease Outbreaks , Mycobacterium Infections/epidemiology , Mycobacterium Infections/physiopathology , Mycobacterium/isolation & purification , Adolescent , Adult , Aged , Child , Coinfection , Female , Humans , Male , Middle Aged , Peru/epidemiology , Young AdultSubject(s)
Brain/pathology , Meningoencephalitis/pathology , Mycobacterium Infections/pathology , Aged , Brain/physiopathology , Diagnosis, Differential , Fatal Outcome , Humans , Male , Meningoencephalitis/diagnosis , Meningoencephalitis/drug therapy , Meningoencephalitis/physiopathology , Mycobacterium Infections/diagnosis , Mycobacterium Infections/drug therapy , Mycobacterium Infections/physiopathologyABSTRACT
BACKGROUND AND PURPOSE: Population study on relationship between nontuberculous mycobacterial (NTM) infection and respiratory failure (RF) is limited. This study evaluated the RF risk, including acute respiratory failure (ARF), chronic respiratory failure (CRF) and ARF on CRF, in patients with NTM infection in Taiwan. METHODS: We used the National Health Insurance Research Database of Taiwan to identify 3864 newly diagnosed NTM patients (NTM cohort) from 1999 to 2009, and 15456 non-NTM patients (non-NTM cohort), frequency matched by demographic status for comparison. Incidence and hazard of developing RF were measured by the end of 2010. RESULTS: The incidence rate of RF was 4.31-fold higher in the NTM cohort than in the non-NTM cohort (44.0 vs.10.2 per 1000 person-years), with an adjusted hazard ratio (HR) of 3.11 (95% CI: 2.73-3.54). The cumulative proportional incidence of RF was 10% higher in the NTM cohort than in the non-NTM cohort (P<0.0001). The RF risk was much greater within 6 months after the diagnosis of NTM infection with a HR of 7.45 (95% CI = 5.50-10.09). Age-specific comparison showed that the younger NTM patients had a higher HR of RF than the elderly NTM patients (HR: 4.42, 95% CI: 3.28-5.96 vs. HR: 2.52, 95% CI: 2.17-2.92). Comorbidity increased the risk of RF in both cohorts, particularly in those with chronic obstructive pulmonary disease. CONCLUSION: Our study suggests patients with NTM infection are at a high risk of RF. The risk appears much greater soon after patients diagnosed with NTM infection.
Subject(s)
Mycobacterium Infections/complications , Respiratory Insufficiency/complications , Aged , Cohort Studies , Female , Humans , Male , Middle Aged , Mycobacterium Infections/physiopathologyABSTRACT
Mycobacterium abscessus is a rapidly growing Mycobacterium causing a wide spectrum of clinical syndromes. It now is recognized as a pulmonary pathogen to which cystic fibrosis patients have a particular susceptibility. The M. abscessus rough (R) variant, devoid of cell-surface glycopeptidolipids (GPLs), causes more severe clinical disease than the smooth (S) variant, but the underlying mechanisms of R-variant virulence remain obscure. Exploiting the optical transparency of zebrafish embryos, we observed that the increased virulence of the M. abscessus R variant compared with the S variant correlated with the loss of GPL production. The virulence of the R variant involved the massive production of serpentine cords, absent during S-variant infection, and the cords initiated abscess formation leading to rapid larval death. Cording occurred within the vasculature and was highly pronounced in the central nervous system (CNS). It appears that M. abscessus is transported to the CNS within macrophages. The release of M. abscessus from apoptotic macrophages initiated the formation of cords that grew too large to be phagocytized by macrophages or neutrophils. This study is a description of the crucial role of cording in the in vivo physiopathology of M. abscessus infection and emphasizes cording as a mechanism of immune evasion.
Subject(s)
Abscess/physiopathology , Cord Factors/metabolism , Glycolipids/metabolism , Glycopeptides/metabolism , Immunologic Factors/metabolism , Mycobacterium Infections/physiopathology , Mycobacterium/pathogenicity , Animals , Clodronic Acid , Cord Factors/immunology , DNA Primers/genetics , Embryo, Nonmammalian , Histocytochemistry , Image Processing, Computer-Assisted , Macrophages/metabolism , Microscopy, Fluorescence , Morpholinos/administration & dosage , Morpholinos/genetics , Mycobacterium/cytology , Mycobacterium/metabolism , Phagocytosis/physiology , Virulence , ZebrafishABSTRACT
PURPOSE OF REVIEW: Inborn errors of human natural killer (NK) cells may affect the development of these cells, their function, or both. There are two broad categories of genetic defects of NK cell development, depending on whether the deficiency is apparently specific to NK cells or clearly affects multiple hematopoietic lineages. We review here recent progress in the genetic dissection of these NK deficiencies (NKDs). RECENT FINDINGS: Patients with severe combined immunodeficiencies bearing mutations of adenosine deaminase, adenylate kinase 2, interleukin-2 receptor gamma chain, and Janus kinase 3 genes present NKDs and are prone to a broad range of infections. Patients with GATA binding protein 2 deficiency are susceptible to both mycobacterial and viral infections, and display NKDs and a lack of monocytes. Rare patients with mini chromosomal maintenance 4 deficiency display an apparently selective NKD associated with viral infections, but they also display various nonhematopoietic phenotypes, including adrenal insufficiency and growth retardation. SUMMARY: These studies have initiated a genetic dissection of the development of human NK cells. Further studies are warranted, including the search for genetic causes of NKD in particular. This research may lead to the discovery of molecules specifically controlling the development of NK cells and to improvements in our understanding of the hitherto elusive function of these cells in humans.
Subject(s)
Adenosine Deaminase/deficiency , Agammaglobulinemia/genetics , Agammaglobulinemia/immunology , Severe Combined Immunodeficiency/genetics , Severe Combined Immunodeficiency/immunology , Adenosine Deaminase/genetics , Adenosine Deaminase/immunology , Adenylate Kinase/genetics , Adenylate Kinase/immunology , Agammaglobulinemia/pathology , Agammaglobulinemia/physiopathology , GATA2 Transcription Factor/genetics , GATA2 Transcription Factor/immunology , Humans , Janus Kinase 2 , Janus Kinase 3/genetics , Janus Kinase 3/immunology , Killer Cells, Natural , Minichromosome Maintenance Complex Component 4/genetics , Minichromosome Maintenance Complex Component 4/immunology , Mycobacterium Infections/genetics , Mycobacterium Infections/immunology , Mycobacterium Infections/pathology , Mycobacterium Infections/physiopathology , Severe Combined Immunodeficiency/pathology , Severe Combined Immunodeficiency/physiopathology , Virus Diseases/genetics , Virus Diseases/immunology , Virus Diseases/pathology , Virus Diseases/physiopathologyABSTRACT
PURPOSE OF REVIEW: There have been exciting recent advances in identifying new mutations that cause human primary immunodeficiencies which impact innate immune defences. In this review, we will highlight the most important and influential advances published in the last 18 months related to the defects of the innate immune system. We will also provide clinical context to facilitate the incorporation of these discoveries into clinical practice. RECENT FINDINGS: We will specifically focus on three areas that have seen recent significant advances: defects in Toll-like receptor signalling that enhance susceptibility to viral infection, particularly herpes simplex encephalitis; defects in innate immunity that impact phagocyte function predisposing to mycobacterial infection; and the discovery of genes responsible for isolated congenital asplenia. SUMMARY: The field of innate immunodeficiency has benefited greatly from the recent improvements in genome sequencing technology and has advanced dramatically in the last 18 months. For clinicians confronted with patients with suspected innate immunodeficiency, these new discoveries not only increase the likelihood that a patient will receive a specific molecular diagnosis and tailored therapy, but also add significant complexity to the diagnostic workup. Future challenges will include identifying accurate, cost-effective diagnostic approaches to these novel immunodeficiencies, so these impressive advances in our understanding of innate immunity can be translated into improved health outcomes for our affected patients and their families.
Subject(s)
Common Variable Immunodeficiency , Immunity, Innate/genetics , Phagocytes , Encephalitis, Herpes Simplex/genetics , Encephalitis, Herpes Simplex/immunology , Encephalitis, Herpes Simplex/pathology , Encephalitis, Herpes Simplex/physiopathology , Genetic Predisposition to Disease , Humans , Immunologic Deficiency Syndromes/genetics , Immunologic Deficiency Syndromes/immunology , Immunologic Deficiency Syndromes/pathology , Immunologic Deficiency Syndromes/physiopathology , Mycobacterium Infections/genetics , Mycobacterium Infections/immunology , Mycobacterium Infections/pathology , Mycobacterium Infections/physiopathology , Phagocytes/immunology , Phagocytes/pathology , Primary Immunodeficiency Diseases , Spleen/abnormalities , Spleen/immunology , Spleen/pathology , Spleen/physiopathology , Toll-Like Receptors/genetics , Toll-Like Receptors/immunologyABSTRACT
The innate immune system, including phagocytic cells, is the first line of defense against pathogens. During infection by microorganisms such as viruses, bacteria, or parasites, phagocytic cells produce an excess of oxidants, a crucial process for the clearance of pathogens. This increase in oxidants creates an imbalance between oxidants and endogenous antioxidants. Left unchecked, this acute or chronic oxidative stress can lead to apoptotic cell-death and oxidative stress-induced diseases including neurodegenerative and cardiovascular disorders, premature aging, secondary infections, and cancer. The activation of nuclear factor E2-related factor 2 (Nrf2) is an efficient antioxidant defensive mechanism used by host cells to counteract oxidative stress. The transcription factor Nrf2 has been identified as the master regulator of several hundred of genes involved in the antioxidant defense response. The review objectives were to collect recent findings on the contribution of oxidative stress to complications of infection, and to highlight the beneficial impact of antioxidants in reducing inflammation and oxidant-related tissue damage. Furthermore, a direct relationship between infection and decline in Nrf2 activity has been demonstrated. Thus, an interesting therapeutic approach in disease prevention and treatment of stress-related diseases may consist in optimizing antibiotic or antiviral therapy with a combination of Nrf2 inducer treatment.
Subject(s)
Communicable Diseases/physiopathology , NF-E2-Related Factor 2/physiology , Oxidative Stress/genetics , Animals , Antioxidants/pharmacology , Antioxidants/therapeutic use , Bacterial Infections/immunology , Bacterial Infections/physiopathology , Communicable Diseases/immunology , Gene Expression Regulation , Host-Pathogen Interactions/immunology , Humans , Immunity, Innate , Intracellular Signaling Peptides and Proteins/physiology , Kelch-Like ECH-Associated Protein 1 , Mice , Molecular Targeted Therapy , Mycobacterium Infections/immunology , Mycobacterium Infections/physiopathology , NF-E2-Related Factor 2/chemistry , NF-E2-Related Factor 2/deficiency , Parasitic Diseases/immunology , Parasitic Diseases/physiopathology , Phagocytosis , Reactive Oxygen Species/metabolism , Transcription, Genetic , Virus Diseases/immunology , Virus Diseases/physiopathologySubject(s)
Cachexia/etiology , Heart Transplantation/adverse effects , Mycobacterium Infections/complications , Mycobacterium Infections/microbiology , Mycobacterium/isolation & purification , Abdominal Pain/microbiology , Anti-Bacterial Agents/therapeutic use , Diarrhea/microbiology , Humans , Male , Middle Aged , Mycobacterium/classification , Mycobacterium/genetics , Mycobacterium Infections/diagnosis , Mycobacterium Infections/drug therapy , Mycobacterium Infections/physiopathology , Weight LossABSTRACT
In the study of complex patterns in biology, mathematical and computational models are emerging as important tools. In addition to experimental approaches, these modeling tools have recently been applied to address open questions regarding host-pathogen interaction dynamics, including the immune response to mycobacterial infection and tuberculous granuloma formation. We present an approach in which a computational model represents the interaction of the Mycobacterium infection with the innate immune system in zebrafish at a high level of abstraction. We use the Petri Net formalism to model the interaction between the key host elements involved in granuloma formation and infection dissemination. We define a qualitative model for the understanding and description of causal relations in this dynamic process. Complex processes involving cell-cell or cell-bacteria communication can be modeled at smaller scales and incorporated hierarchically into this main model; these are to be included in later elaborations. With the infection mechanism being defined on a higher level, lower-level processes influencing the host-pathogen interaction can be identified, modeled, and tested both quantitatively and qualitatively. This systems biology framework incorporates modeling to generate and test hypotheses, to perform virtual experiments, and to make experimentally verifiable predictions. Thereby it supports the unraveling of the mechanisms of tuberculosis infection.
Subject(s)
Computational Biology/methods , Models, Immunological , Mycobacterium Infections/immunology , Mycobacterium Infections/physiopathology , Mycobacterium tuberculosis/metabolism , Animals , Cell Communication , Host-Pathogen Interactions , Humans , Immunity, Innate , Mycobacterium tuberculosis/immunology , Zebrafish/embryology , Zebrafish/metabolismABSTRACT
INTRODUCTION: The impact of pulmonary nontuberculous mycobacterial (pNTM) disease on health-related quality of life (HRQL) has not been quantified. METHODS: We performed a prospective observational study of HRQL in 51 patients with pNTM disease. One generic (Short-form 36, version 2 -SF-36), and one pulmonary disease-specific instrument (St. George's Respiratory Questionnaire--SGRQ) were administered to each subject. RESULTS: Fifty-one patients with pNTM disease from one ambulatory clinic were enrolled. The mean (sd) age was 67 (10) years and 80% (41/51) were female. The most common causative NTM was MAC in 84% (43/51) followed by Mycobacterium abscessus in 8% (4/51). Radiographic disease type was nodular bronchiectasis in 71% (36/51) and fibrocavitary in 22% (11/51). For SF-36, most raw scores were at least 10 points below Canadian population-based normals, and all normbased scores were below the expected normal value of 50. For SGRQ, all scores were worse by ≥ 25 points compared with published normals. In multivariable analyses, only FVC and DLCO were significantly associated with SF-36, and only FVC and emphysema were significantly associated with SGRQ. CONCLUSION: Patients with pNTM disease have significantly impaired HRQL that is most closely associated with lung function and not readily explained by age, sex or extra-pulmonary comorbidity.
Subject(s)
Forced Expiratory Volume , Lung Diseases/microbiology , Lung Diseases/physiopathology , Mycobacterium Infections/physiopathology , Quality of Life , Aged , Cross-Sectional Studies , Female , Health Status , Humans , Male , Mycobacterium Infections/microbiology , Prospective Studies , Severity of Illness Index , Sickness Impact Profile , Surveys and QuestionnairesABSTRACT
This unit describes the infection of mice and guinea pigs with mycobacteria via various routes, as well as necropsy methods for the determination of mycobacterial loads within target organs. Additionally, methods for cultivating mycobacteria and preparing stocks are described. The protocols outlined are primarily used for M. tuberculosis, but can also be used for the study of other non-tuberculosis mycobacterial species.
Subject(s)
Disease Models, Animal , Mycobacterium Infections/immunology , Mycobacterium/immunology , Animals , Animals, Genetically Modified , Disease Progression , Guinea Pigs , Humans , Immunity , Mice , Mycobacterium/pathogenicity , Mycobacterium Infections/physiopathologyABSTRACT
BACKGROUND: The HIV pandemic raised the potential for facultative-pathogenic mycobacterial species like, Mycobacterium kansasii, to cause disseminating disease in humans with immune deficiencies. In contrast, non-pathogenic mycobacterial species, like M. smegmatis, are not known to cause disseminating disease even in immunocompromised individuals. We hypothesized that this difference in phenotype could be explained by the strong induction of an innate immune response by the non-pathogenic mycobacterial species. RESULTS: A comparison of two rapid-growing, non-pathogenic species (M. smegmatis and M. fortuitum) with two facultative-pathogenic species (M. kansasii and M. bovis BCG) demonstrated that only the non-pathogenic bacteria induced strong apoptosis in human THP-1 cells and murine bone marrow-derived macrophages (BMDM) and dendritic cells (BMDD). The phospho-myo-inositol modification of lipoarabinomannan (PI-LAM) isolated from non-pathogenic species may be one of the cell wall components responsible for the pro-inflammatory activity of the whole bacteria. Indeed, PI-LAM induces high levels of apoptosis and IL-12 expression compared to the mannosyl modification of LAM isolated from facultative-pathogenic mycobacteria. The apoptosis induced by non-pathogenic M. smegmatis was dependent upon caspase-3 activation and TNF secretion. Consistently, BALB/c BMDM responded by secreting large amounts of TNF upon infection with non-pathogenic but not facultative-pathogenic mycobacteria. Interestingly, C57Bl/6 BMDM do not undergo apoptosis upon infection with non-pathogenic mycobacteria despite the fact that they still induce an increase in TNF secretion. This suggests that the host cell signaling pathways are different between these two mouse genotypes and that TNF is necessary but not sufficient to induce host cell apoptosis. CONCLUSION: These results demonstrate a much stronger induction of the innate immune response by non-pathogenic versus facultative-pathogenic mycobacteria as measured by host cell apoptosis, IL-12 and TNF cytokine induction. These observations lend support to the hypothesis that the strong induction of the innate immune response is a major reason for the lack of pathogenicity in fast-growing mycobacteria.
Subject(s)
Apoptosis , Caspase 3/immunology , Host-Pathogen Interactions , Mycobacterium Infections/physiopathology , Mycobacterium/physiology , Signal Transduction , Tumor Necrosis Factor-alpha/immunology , Animals , Cell Line , Cells, Cultured , Dendritic Cells/cytology , Dendritic Cells/immunology , Dendritic Cells/microbiology , Humans , Macrophages/cytology , Macrophages/immunology , Macrophages/microbiology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mycobacterium/pathogenicity , Mycobacterium Infections/enzymology , Mycobacterium Infections/immunology , Mycobacterium Infections/microbiologyABSTRACT
BACKGROUND: Nontuberculous mycobacteria (NTM) are emerging opportunistic pathogens whose role in human and animal disease is increasingly being recognized. Major concerns are their role as opportunistic pathogens in HIV/AIDS infections. The role of open natural water sources as source and livestock/wildlife as reservoirs of infections to man are well documented. This presents a health challenge to the pastoral systems in Africa that rely mostly on open natural water sources to meet livestock and human needs. Recent study in the pastoral areas of Uganda showed infections with same genotypes of NTM in pastoralists and their livestock. The aim of this study was to determine the environmental, animal husbandry and socio-demographic factors associated with occurrence and the pastoral community knowledge of mycobacterial infections at the human-environment-livestock/wildlife interface (HELI) areas in pastoral ecosystems of Uganda. METHODS: Two hundred and fifty three (253) individuals were subjected to a questionnaire survey across the study districts of Nakasongola and Mubende. Data were analyzed using descriptive statistics and multivariable logistic regression analysis. RESULTS: Humans sharing of the water sources with wild animals from the forest compared to savannah ecosystem (OR = 3.3), the tribe of herding pastoral community (OR = 7.9), number of rooms present in household (3-5 vs. 1-2 rooms) (OR = 3.3) were the socio-demographic factors that influenced the level of knowledge on mycobacterial infections among the pastoral communities. Tribe (OR = 6.4), use of spring vs. stream water for domestic use (OR = 4.5), presence of sediments in household water receptacle (OR = 2.32), non separation of water containers for drinking and domestic use (OR = 2.46), sharing of drinking water sources with wild animals (OR = 2.1), duration of involvement of >5 yrs in cattle keeping (OR = 3.7) and distance of household to animal night shelters (>20 meters) (OR = 3.8) were significant socio-demographic factors associated with the risk of occurrence of mycobacterioses among the pastoral communities in Uganda. CONCLUSION: The socio-demographic, environmental and household related factors influence the risk of occurrence as well as pastoralists' knowledge of mycobacterial infections in the pastoral households at the human-environment-livestock/wildlife pastoral interface areas of Uganda.
Subject(s)
Health Knowledge, Attitudes, Practice , Livestock/microbiology , Mycobacterium Infections/epidemiology , Zoonoses/transmission , Animal Husbandry , Animals , Female , Humans , Male , Mycobacterium/isolation & purification , Mycobacterium Infections/physiopathology , Mycobacterium Infections/transmission , Socioeconomic Factors , Uganda/epidemiologyABSTRACT
The isolation of nontuberculous mycobacteria (NTM) from clinical specimens has become very frequent in the last years. Such organisms are typically environmental and poorly pathogenic for humans; they can, however, be responsible for opportunistic diseases in subjects presenting with various predisposing conditions. Pulmonary infections are responsible for the most frequent disease caused by NTM, although the relevance of mycobacterioses involving other parts of the body is increasing. The risk of disseminated infections characterizing immunocompromised patients is well known, and those numbers are steadily rising. The lymph nodes, cutis and soft tissues, as well as bone and joints, are also important targets of NTM infection. The problems concerning the assessment of the clinical significance of NTM, along with a consideration of the more frequent NTM pathologies, are the major objectives of this review.
Subject(s)
Mycobacterium Infections/pathology , Mycobacterium Infections/physiopathology , Mycobacterium/isolation & purification , Environmental Microbiology , Humans , Immunocompromised Host , Lymphadenitis/microbiology , Mycobacterium Infections/epidemiology , Mycobacterium Infections/microbiology , Respiratory Tract Infections/microbiology , Skin Diseases, Bacterial/microbiology , Soft Tissue Infections/microbiologyABSTRACT
Hepcidin is an antimicrobial peptide involved in regulating iron homeostasis. It is induced by iron overload and decreased by hypoxia and anemia. Hepcidin regulates iron metabolism by inhibiting iron absorption by the duodenum and by inhibiting macrophage iron recycling. Hepcidin is induced in hepatocytes during the acute-phase response by IL-6. Previously, we have shown that hepcidin is not induced in macrophages by IL-6 but is induced by the synergistic interaction of IFN-gamma and Mycobacterium tuberculosis infection. In the present study, we examined the pathways involved in inducing macrophage hepcidin expression. We show that TLRs TLR2 and TLR4 and the transcription factor STAT1 are required for induction of hepcidin mRNA. Hepcidin promoter activity is also synergistically induced in RAW264.7 macrophages by IFN-gamma and M. tuberculosis. NF-kappaB and C/CEBP binding sites are required for promoter activity. Binding of NF-kappaB (p50/p65) to the NF-kappaB site and STAT1 and C/EBPbeta to the C/CEBP site was confirmed by EMSA. Knockdown of STAT1 and C/EBPbeta expression in RAW264.7 cells with siRNA plasmids inhibited hepcidin promoter activity induced by IFN-gamma and M. tuberculosis. Together, these studies demonstrate that macrophage hepcidin expression is induced by the activation of STAT1 and NF-kappaB and the induction of C/EBPbeta expression.
Subject(s)
Antimicrobial Cationic Peptides/genetics , CCAAT-Enhancer-Binding Protein-beta/physiology , Interferon-gamma/physiology , Mycobacterium Infections/physiopathology , NF-kappa B/physiology , STAT1 Transcription Factor/physiology , Transcription, Genetic , Animals , Bone Marrow Cells/cytology , DNA Primers , Gene Expression Regulation , Hepcidins , Interferon-gamma/genetics , Interferon-gamma/pharmacology , Macrophages/cytology , Mice , Mice, Inbred C57BL , Microscopy, Confocal , Mycobacterium Infections/genetics , Mycobacterium Infections/pathology , Promoter Regions, Genetic , RNA, Messenger/genetics , RNA, Messenger/isolation & purification , Restriction Mapping , Reverse Transcriptase Polymerase Chain ReactionABSTRACT
Mycobacteria are characterized by a complex cell wall, the lipid nature of which confers to the bacilli resistance to drying, acid or alkaline conditions, and to chemical disinfectants and therapeutic agents. Pathogenic species, such as Mycobacterium tuberculosis, M. leprae and M. ulcerans, have evolved various strategies to establish residence in their hosts and provoke long-term infections. There is mounting evidence that the unique lipids composing their envelopes, strategically located at the host-pathogen interface, contribute to their escape from immune surveillance. Here, the chemical structure, host cell receptors and biological actions of this emerging class of mycobacterial virulence factors are reviewed.